# 2026-04970: Purisys Eyes Importing Marijuana Extracts – Public Input Sought

2026-04970, Importer of Controlled Substances Application: Purisys, LLC, is a Federal Register notice from Justice Department, Drug Enforcement Administration published 2026-03-13, effective Registered bulk manufacturers of the affected basic class(es), and applicants, therefore, may submit electronic comments on or objections to the issuance of the proposed registration on or before April 13, 2026. Such persons may also file a written request for a hearing on the application on or before April 13, 2026.; PRIA reads it as touching household money (as of 2026-06-08).

- Canonical: https://policyrisk.com/federal-register/2026-04970
- As of: 2026-06-08
- Plain-text twin of the page above; the HTML and this file carry the same facts.

## Facts
- Document number: 2026-04970
- Title: Importer of Controlled Substances Application: Purisys, LLC
- Type: Notice
- Agencies: Justice Department; Drug Enforcement Administration
- Citation: 91 FR 12446
- Published: 2026-03-13
- Effective: Registered bulk manufacturers of the affected basic class(es), and applicants, therefore, may submit electronic comments on or objections to the issuance of the proposed registration on or before April 13, 2026. Such persons may also file a written request for a hearing on the application on or before April 13, 2026.
- Comments close: 2026-04-13
- Significant: no
- Touches household money: yes
- Regulation identifier numbers: none
- Last updated: 2026-06-08

## In one line

Purisys Eyes Importing Marijuana Extracts – Public Input Sought

## Summary

Purisys, LLC wants to become an official importer of certain controlled substances like marijuana and its extracts. People and companies involved can share their thoughts or ask for a hearing by April 13, 2026. This move could affect businesses handling these substances and might change how imports are managed, but no costs are mentioned yet.

## Abstract

Purisys, LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

## Effects PRIA read

- Application to Import Many Controlled Drugs: mixed, low. Purisys, LLC filed an application on February 4, 2026 to be registered as an importer of a list of controlled substances (including Marihuana Extract 7350, Marihuana 7360, Tetrahydrocannabinols 7370, and multiple Schedule II drugs such as Methadone 9250 and Thebaine 9333). The notice lists each dru…
- Opium Imports for API Manufacturing: benefit, medium. Purisys plans to import Opium, Raw (9600), Opium, Powdered (9639), and Opium, Granulated (9640) specifically to manufacture an Active Pharmaceutical Ingredient (API) only for distribution to its customers. The company states these imports are intended solely for API manufacture.
- Bulk Manufacture Inputs: Phenylacetone & Poppy Straw: benefit, medium. Purisys plans to import Phenylacetone (8501) and Poppy Straw Concentrate (9670) to bulk manufacture other controlled substances for distribution to its customers. The company explicitly states these imports are for bulk manufacture.
- No Import of Finished Dosage Forms Allowed: cost, medium. The notice states that approval will not extend to the import of Food and Drug Administration-approved or non-approved finished dosage forms for commercial sale. Registrants must have business activity consistent with 21 U.S.C. 952(a)(2) to receive authorization.

## Related documents

- [2026-11526](https://policyrisk.com/federal-register/2026-11526): Implementation of the Substance Use-Disorder Prevention That Promotes Opioid Recovery and Treatment for Patients and Communities Act of 201…, 2026-06-09
- [2026-10128](https://policyrisk.com/federal-register/2026-10128): Revision of Applications for Manufacturing and Procurement Quotas, 2026-05-20
- [2025-05007](https://policyrisk.com/federal-register/2025-05007): Expansion of Buprenorphine Treatment via Telemedicine Encounter and Continuity of Care via Telemedicine for Veterans Affairs Patients, 2025-03-24
- [2025-02793](https://policyrisk.com/federal-register/2025-02793): Expansion of Buprenorphine Treatment via Telemedicine Encounter and Continuity of Care via Telemedicine for Veterans Affairs Patients, 2025-02-19
- [2026-22843](https://policyrisk.com/federal-register/2026-22843): Proposed Aggregate Production Quotas for Schedule I and II Controlled Substances and Assessment of Annual Needs for the List I Chemicals Ep…, 2026-11-10
- [2026-22842](https://policyrisk.com/federal-register/2026-22842): Adjustment to the 2026 Aggregate Production Quota for d,l-Amphetamine, d-Amphetamine (for Sale), Hydromorphone and Methylphenidate (for Sal…, 2026-11-10

## Sources
- [2026-04970 on federalregister.gov](https://www.federalregister.gov/documents/2026/03/13/2026-04970/importer-of-controlled-substances-application-purisys-llc)
- [2026-04970 as published (PDF)](https://www.govinfo.gov/content/pkg/FR-2026-03-13/pdf/2026-04970.pdf)

## Related
- [Previous: 2026-04969, Bulk Manufacturer of Controlled Substances Application: Stepan Company](https://policyrisk.com/federal-register/2026-04969)
- [Next: 2026-04971, Bulk Manufacturer of Controlled Substances Application: Pisgah Laboratories Inc](https://policyrisk.com/federal-register/2026-04971)
- [All Federal Register documents](https://policyrisk.com/federal-register)

Source: PRIA, https://policyrisk.com/federal-register/2026-04970 (as of 2026-06-08).
